Evolutionary and comparative genomics to drive rational drug design, with particular focus on neuropeptide seven-transmembrane receptors

Michael Furlong, Jae Young Seong

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Seven transmembrane receptors (7TMRs), also known as G protein-coupled receptors, are popular targets of drug development, particularly 7TMR systems that are activated by peptide ligands. Although many pharmaceutical drugs have been discovered via conventional bulk analysis techniques the increasing availability of structural and evolutionary data are facilitating change to rational, targeted drug design. This article discusses the appeal of neuropeptide-7TMR systems as drug targets and provides an overview of concepts in the evolution of vertebrate genomes and gene families. Subsequently, methods that use evolutionary concepts and comparative analysis techniques to aid in gene discovery, gene function identification, and novel drug design are provided along with case study examples.

Original languageEnglish
Pages (from-to)57-68
Number of pages12
JournalBiomolecules and Therapeutics
Volume25
Issue number1
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Drug Design
Genomics
Neuropeptides
Genes
Pharmaceutical Preparations
Genetic Association Studies
G-Protein-Coupled Receptors
Vertebrates
Genome
Ligands
Peptides
Availability

Keywords

  • 7TMR
  • Coevolution
  • Evolutionary history
  • G protein-coupled receptor
  • Gene duplication
  • Neuropeptide
  • Whole genome duplication

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

@article{1429a4b117244ecbaac0cdd00fe53121,
title = "Evolutionary and comparative genomics to drive rational drug design, with particular focus on neuropeptide seven-transmembrane receptors",
abstract = "Seven transmembrane receptors (7TMRs), also known as G protein-coupled receptors, are popular targets of drug development, particularly 7TMR systems that are activated by peptide ligands. Although many pharmaceutical drugs have been discovered via conventional bulk analysis techniques the increasing availability of structural and evolutionary data are facilitating change to rational, targeted drug design. This article discusses the appeal of neuropeptide-7TMR systems as drug targets and provides an overview of concepts in the evolution of vertebrate genomes and gene families. Subsequently, methods that use evolutionary concepts and comparative analysis techniques to aid in gene discovery, gene function identification, and novel drug design are provided along with case study examples.",
keywords = "7TMR, Coevolution, Evolutionary history, G protein-coupled receptor, Gene duplication, Neuropeptide, Whole genome duplication",
author = "Michael Furlong and Seong, {Jae Young}",
year = "2017",
month = "1",
day = "1",
doi = "10.4062/biomolther.2016.199",
language = "English",
volume = "25",
pages = "57--68",
journal = "Biomolecules and Therapeutics",
issn = "1976-9148",
publisher = "Korean Society of Applied Pharmacology",
number = "1",

}

TY - JOUR

T1 - Evolutionary and comparative genomics to drive rational drug design, with particular focus on neuropeptide seven-transmembrane receptors

AU - Furlong, Michael

AU - Seong, Jae Young

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Seven transmembrane receptors (7TMRs), also known as G protein-coupled receptors, are popular targets of drug development, particularly 7TMR systems that are activated by peptide ligands. Although many pharmaceutical drugs have been discovered via conventional bulk analysis techniques the increasing availability of structural and evolutionary data are facilitating change to rational, targeted drug design. This article discusses the appeal of neuropeptide-7TMR systems as drug targets and provides an overview of concepts in the evolution of vertebrate genomes and gene families. Subsequently, methods that use evolutionary concepts and comparative analysis techniques to aid in gene discovery, gene function identification, and novel drug design are provided along with case study examples.

AB - Seven transmembrane receptors (7TMRs), also known as G protein-coupled receptors, are popular targets of drug development, particularly 7TMR systems that are activated by peptide ligands. Although many pharmaceutical drugs have been discovered via conventional bulk analysis techniques the increasing availability of structural and evolutionary data are facilitating change to rational, targeted drug design. This article discusses the appeal of neuropeptide-7TMR systems as drug targets and provides an overview of concepts in the evolution of vertebrate genomes and gene families. Subsequently, methods that use evolutionary concepts and comparative analysis techniques to aid in gene discovery, gene function identification, and novel drug design are provided along with case study examples.

KW - 7TMR

KW - Coevolution

KW - Evolutionary history

KW - G protein-coupled receptor

KW - Gene duplication

KW - Neuropeptide

KW - Whole genome duplication

UR - http://www.scopus.com/inward/record.url?scp=85008392764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008392764&partnerID=8YFLogxK

U2 - 10.4062/biomolther.2016.199

DO - 10.4062/biomolther.2016.199

M3 - Article

AN - SCOPUS:85008392764

VL - 25

SP - 57

EP - 68

JO - Biomolecules and Therapeutics

JF - Biomolecules and Therapeutics

SN - 1976-9148

IS - 1

ER -